Global B Cell Maturation Antigen Targeted Therapies Market

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research Report 2021

Global B Cell Maturation Antigen Targeted Therapies Market

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research Report 2021

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that B-Cell Maturation Antigen(BCMA) Targeted Therapies Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview:

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of B-Cell Maturation Antigen(BCMA) Targeted Therapies involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on B-Cell Maturation Antigen(BCMA) Targeted Therapies Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the B-Cell Maturation Antigen(BCMA) Targeted Therapies market in 2020.

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Segmentation

By Type, B-Cell Maturation Antigen(BCMA) Targeted Therapies market has been segmented into:

Bispecific Antibodies

Antibody Drug Conjugates

Chimeric Antigen Receptor T-Cells

By Application, B-Cell Maturation Antigen(BCMA) Targeted Therapies market has been segmented into:

Liver Cancer

Respiratory Cancer

Brain Cancer

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in B-Cell Maturation Antigen(BCMA) Targeted Therapies market are:

Transposagen Biopharmaceuticals

Sutro Biopharma

Malin Corporation

Eureka Therapeutics

firstVentury Equity

Five Prime Therapeutics

Credit Suisse Securities

Dana-Farber Cancer Institute

Deerfield Partners

Onyx Pharmaceuticals

Juno Therapeutics

1. Market Overview of B-Cell Maturation Antigen(BCMA) Targeted Therapies

1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview

1.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Scope

1.1.2 Market Status and Outlook

1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2015 VS 2021 VS 2026

1.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Regions (2015-2020)

1.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market by Type (2015-2026)

2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2015-2020)

2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2021-2026)

2.3 Bispecific Antibodies

2.4 Antibody Drug Conjugates

2.5 Chimeric Antigen Receptor T-Cells

3. Covid-19 Impact B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market by Application (2015-2026)

3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Application (2015-2020)

3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2021-2026)

3.3 Liver Cancer

3.4 Respiratory Cancer

3.5 Brain Cancer

3.6 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Manufacturers (2015-2020)

4.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business

5.1 Transposagen Biopharmaceuticals

5.1.1 Transposagen Biopharmaceuticals Company Profile

5.1.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Sutro Biopharma

5.2.1 Sutro Biopharma Company Profile

5.2.2 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Malin Corporation

5.3.1 Malin Corporation Company Profile

5.3.2 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Eureka Therapeutics

5.4.1 Eureka Therapeutics Company Profile

5.4.2 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 firstVentury Equity

5.5.1 firstVentury Equity Company Profile

5.5.2 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Five Prime Therapeutics

5.6.1 Five Prime Therapeutics Company Profile

5.6.2 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Credit Suisse Securities

5.7.1 Credit Suisse Securities Company Profile

5.7.2 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Dana-Farber Cancer Institute

5.8.1 Dana-Farber Cancer Institute Company Profile

5.8.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Deerfield Partners

5.9.1 Deerfield Partners Company Profile

5.9.2 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Onyx Pharmaceuticals

5.10.1 Onyx Pharmaceuticals Company Profile

5.10.2 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Juno Therapeutics

5.11.1 Juno Therapeutics Company Profile

5.11.2 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification

5.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

6.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

7.2 East Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

7.3 East Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

7.4 East Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

8. Europe

8.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

8.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

8.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

8.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

9.2 South Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

9.3 South Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

9.4 South Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

10.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

10.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

10.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

11.2 Middle East B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

11.3 Middle East B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

11.4 Middle East B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

12. Africa

12.1 Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

12.2 Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

12.3 Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

12.4 Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

13.2 Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

13.3 Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

13.4 Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

14. South America

14.1 South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

14.2 South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

14.3 South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

14.4 South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2026)

15.2 Rest of the World B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2015-2020)

15.3 Rest of the World B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)

15.4 Rest of the World B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

16 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
B Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the B Cell Maturation Antigen(BCMA) Targeted Therapies Market?
Some of the finest and top-notch companies pioneering the B Cell Maturation Antigen(BCMA) Targeted Therapies Market are Transposagen Biopharmaceuticals, Sutro Biopharma, Malin Corporation, Eureka Therapeutics, firstVentury Equity, Five Prime Therapeutics, Credit Suisse Securities, Dana-Farber Cancer Institute, Deerfield Partners, Onyx Pharmaceuticals, Juno Therapeutics.
How is the competition changing gears in the B Cell Maturation Antigen(BCMA) Targeted Therapies Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Transposagen Biopharmaceuticals, Sutro Biopharma, Malin Corporation, Eureka Therapeutics, firstVentury Equity, Five Prime Therapeutics, Credit Suisse Securities, Dana-Farber Cancer Institute, Deerfield Partners, Onyx Pharmaceuticals, Juno Therapeutics will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Where are the B Cell Maturation Antigen(BCMA) Targeted Therapies used?
The B Cell Maturation Antigen(BCMA) Targeted Therapies are employed in Liver Cancer, Respiratory Cancer, Brain Cancer, Others.
What years are taken into account in the B Cell Maturation Antigen(BCMA) Targeted Therapies Market study?
The B Cell Maturation Antigen(BCMA) Targeted Therapies Market study evaluates the year spans as follows: Historical year: 2019 to 2024; Base year: 2024; Forecast period**: 2025 to 2030 [** unless otherwise stated]
In the current situation, what value does the B Cell Maturation Antigen(BCMA) Targeted Therapies Market have?
The value of the B Cell Maturation Antigen(BCMA) Targeted Therapies Market is estimated to be USD XXX million.
What are the primary data sources used to evaluate the B Cell Maturation Antigen(BCMA) Targeted Therapies Market sizing?
The majority of data for the B Cell Maturation Antigen(BCMA) Targeted Therapies Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.